- Home
- WAL vs KZR Comparison
WAL vs KZR Comparison
Compare WAL & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAL
- KZR
- Stock Information
- Founded
- WAL 1994
- KZR 2015
- Country
- WAL United States
- KZR United States
- Employees
- WAL N/A
- KZR N/A
- Industry
- WAL Major Banks
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- WAL Finance
- KZR Health Care
- Exchange
- WAL Nasdaq
- KZR Nasdaq
- Market Cap
- WAL 10.1B
- KZR 29.7M
- IPO Year
- WAL 2005
- KZR 2018
- Fundamental
- Price
- WAL $88.88
- KZR $3.74
- Analyst Decision
- WAL Strong Buy
- KZR Hold
- Analyst Count
- WAL 13
- KZR 2
- Target Price
- WAL $97.62
- KZR $9.00
- AVG Volume (30 Days)
- WAL 1.0M
- KZR 30.5K
- Earning Date
- WAL 10-16-2025
- KZR 11-11-2025
- Dividend Yield
- WAL 1.71%
- KZR N/A
- EPS Growth
- WAL 14.60
- KZR N/A
- EPS
- WAL 7.61
- KZR N/A
- Revenue
- WAL $3,120,700,000.00
- KZR N/A
- Revenue This Year
- WAL $14.78
- KZR N/A
- Revenue Next Year
- WAL $10.40
- KZR N/A
- P/E Ratio
- WAL $11.67
- KZR N/A
- Revenue Growth
- WAL 10.46
- KZR N/A
- 52 Week Low
- WAL $57.05
- KZR $3.62
- 52 Week High
- WAL $98.10
- KZR $9.18
- Technical
- Relative Strength Index (RSI)
- WAL 56.94
- KZR 35.98
- Support Level
- WAL $85.43
- KZR $3.76
- Resistance Level
- WAL $91.61
- KZR $4.05
- Average True Range (ATR)
- WAL 2.27
- KZR 0.13
- MACD
- WAL -0.37
- KZR -0.01
- Stochastic Oscillator
- WAL 43.89
- KZR 6.82
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.